What are we treating with opioid and sedative-hypnotic combination therapy?
about
Assessment of direct gating and allosteric modulatory effects of meprobamate in recombinant GABA(A) receptors.Implementation of a pharmacy consult to reduce co-prescribing of opioids and benzodiazepines in a Veteran population.Postsurgical prescriptions for opioid naive patients and association with overdose and misuse: retrospective cohort study.
P2860
What are we treating with opioid and sedative-hypnotic combination therapy?
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh-hant
name
What are we treating with opioid and sedative-hypnotic combination therapy?
@en
What are we treating with opioid and sedative-hypnotic combination therapy?
@nl
type
label
What are we treating with opioid and sedative-hypnotic combination therapy?
@en
What are we treating with opioid and sedative-hypnotic combination therapy?
@nl
prefLabel
What are we treating with opioid and sedative-hypnotic combination therapy?
@en
What are we treating with opioid and sedative-hypnotic combination therapy?
@nl
P2860
P356
P1476
What are we treating with opioid and sedative-hypnotic combination therapy?
@en
P2093
Mark D Sullivan
P2860
P304
P356
10.1002/PDS.3821
P577
2015-06-22T00:00:00Z